Caduet Drug Use Investigation (Regulatory Post Marketing Commitment Plan).
Phase of Trial: Phase IV
Latest Information Update: 29 May 2013
At a glance
- Drugs Amlodipine/atorvastatin (Primary)
- Indications Angina pectoris; Hypercholesterolaemia; Hyperlipoproteinaemia type IIa; Hypertension
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 15 May 2012 Actual patient number 1291 added as reported by ClinicalTrials.gov.
- 15 May 2012 Actual end date (April 2012) added as reported by ClinicalTrials.gov.
- 15 May 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.